Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells

Lupus

Volumn 15, Issue 12, 2006, Pages 852-857

  Li, X ^a,b   Rider, Virginia ^a   Kimler, B F ^c   Abdou, N I ^d  

^a PITTSBURG STATE UNIVERSITY   (United States)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d Center for Rheumatic Disease   (United States)

Author keywords

CD154; Estrogen; mRNA stability; SLE; T cell

Indexed keywords

CD3 ANTIBODY; CD40 LIGAND; DACTINOMYCIN; ESTRADIOL; ESTROGEN; MESSENGER RNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; RNA SYNTHESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSCRIPTION INITIATION;

ADULT; CD40 LIGAND; CELLS, CULTURED; ESTRADIOL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MIDDLE AGED; RNA STABILITY; RNA, MESSENGER; T-LYMPHOCYTES; TRANS-ACTIVATION (GENETICS);

EID: 33845988068     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203306071314     Document Type: Article

References (54)

1. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-243.
2. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999; 283: 1277-1278.
3. Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1978; 147: 1568-1583.
4. Dhaher YY, Chan K, Greenstein BD, de Fougerolles Nunn E, Khamashata MA, Hughes GR. Impaired estradiol priming of progesterone receptors in the uterus of MRL/Mp-lpr/lpr mice, a model of systemic lupus erythematosus (SLE). Ira J Immunopharmacol 2000; 22: 537-547.
5. Roa R, Greenstein BD. Evidence for pleomorphism of estradiol receptor capacity and affinity in liver and thymus of immature BALB/c and (NZBxNZW) F1 mice, a model of systemic lupus erythematosus. Int J Immunopharmacol 2000; 22: 897-903.
6. Wu W-M, Lin B-F, Su Y-C, Suen J-L, Chiang, B-L. Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune NZB/W F1 mice. Scan J Immunol 2000; 52: 393-400.
7. Apelgren LD, Bailey DL, Fouts RL et al. The effect of a selective estradiol receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Cell Immunol 1996; 173: 55-63.
8. Grimaldi CM, Michael DJ, Diamond B. Cutting edge: Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001; 167: 1886-1890.
9. Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B. Estradiol alters thresholds for B cell apoptosis and activation. J Clin Invest 2002; 109: 1625-1633.
10. Petti M, Kim MY, Kalunian KC et al. Combined oral contraceptives in women with systemic lupus erythematosus. New Engl J Med 2005, 353: 2550-2558.
11. Sanchez-Guerrero J, Uribe AG, Jimenez-Santan L et al. A trial of contraceptive methods in women with systemic lupus erythematosus. New Engl J Med 353: 2539-2549.
12. Ahmed AS, Hissong BD, Verthelyi D, Donner K, Becker K, Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: Possible role of estrogenic compounds. Environ Health Perspect 1999; 107: 681-686.
13. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999; 11: 352-356.
14. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M. Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 1991; 40: 619-637.
15. Maas K, Chan S, Parker J et al. Cutting edge: molecular portrait of human autoimmune disease. J Immunol 2002; 169: 5-9.
16. Rider V, Foster RT, Evans M, Suenaga R, Abdou NI. Gender differences in autoimmune diseases: Estradiol increases calcineurin expression in systemic lupus erythematosus. Clin Immunol Immunopathol 1998; 89: 171-180.
17. Rider V, Jones S, Evans M, Bassiri H, Afsar Z, Abdou NI. Estradiol increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol 2001; 28: 2644-2649.
18. Suenaga R, Rider V, Evans M, Abdou NI. Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estradiol receptor transcripts similar to those of normal cells. J Rheumatol 1998; 25: 1305-1312.
19. Suenaga R, Rider V, Evans MJ, Abdou NI. In vitro-activated human lupus T cells express normal estradiol receptor proteins which bind to the estradiol response element. Lupus 2001; 10: 116-122.
20. Rider V, Jones SR, Evans M, Abdou NI. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol 2000; 95: 124-134.
21. Rider V, Abdou NI. Gender differences in autoimmunity: Molecular basis for estradiol effects in systemic lupus erythematosus. Int Immunopharm 2001; 1: 1009-1024.
22. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Increased 16 alpha hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981; 53: 174-178.
23. Lahita RG. Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am 2000; 26: 951-968.
24. Routsias JG, Vlachoyiannopoulos PG, Tzioufas AG. Autoantibodies to intracellular autoantigens and their B-cell epitopes: Molecular probes to study the autoimmune response. Crit Rev Clin Lab Sci 2006; 43: 203-248.
25. Cron RQ. CD154 Transcriptional regulation in primary human CD4 T cells. Immunologic Res 2003; 3: 185-202.
26. Datta SK, Kalled SL. CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 1997; 40: 1735-1745.
27. Kalled SL, Cutler AH, Datta SK, Thomas DW. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: Preservation of kidney function. J Immunol 1998; 160: 2158-2165.
28. Higuchi T, Aiba Y, Nomura T et al. Cutting edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol 2002; 168: 9-12.
29. Santo-Argumendo L, Alvarez-Maya I, Romero-Ramierez H et al. Enforced and prolonged CD40 ligand expression triggers autoantibody production in vivo. Eur J Immunol 2001; 31: 3484-3492.
30. Koshy M, Berger D, Crow MK. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996; 98: 826-837.
31. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996; 97: 2063-2073.
32. Cron RQ, Bandyopadhyay R, Genin A et al. Early growth response-1 is required for CD154 transcription. J Immunol 2006; 176: 811-818.
33. Mishra N, Brown DR, Olorenshaw IM, Kammer GM. Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells. Proc Natl Acad Sci USA 2001; 98: 2628-2633.
34. Singh K, Laughlin J, Kosinski PA, Covey LR. Nucleolin is a second component of the CD154 mRNA stability complex that regulates mRNA turnover in activated T cells. J Immunol 2004; 73: 976-985.
35. Ford GS, Barnhart B, Shone S, Covey LR. Regulation of CD154 (CD40 Ligand) mRNA stability during T cell activation. J Immunol 1999; 162: 4037-4044.
36. Tsai M-J, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994; 63: 451-486.
37. Ing NH. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol Reprod 2005; 72: 1290-1296.
38. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
39. Rider V, Keltner S, Abdou NI. Increased estrogen-dependent expression of calcineurin in female SLE T cells is regulated by multiple mechanisms. J Gend Specif Med 2003; 6: 14-21.
40. MacDonald KP, Nishioka Y, Lipsky PE, Thomas R. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 1997; 100: 2404-2414.
41. Battaglia E, Biancone L, Resegotti A, Amanuelli G, Fronda GR, Camussi G. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease. Am J Gastroenterol 1999; 94: 3270-3284.
42. Kosinski PA, Laughlin J, Singh K, Covey LR. A complex containing polypyrimidine tract-binding protein is involved in regulating the stability of CD40 ligand (CD154) mRNA. J Immunol 2003; 170: 979-988.
43. Solakidi S, Psarra AM, Sekeris CE. Differential subcellular distribution of estrogen receptor isoforms: localization of ERalpha in the nucleoli and ERbeta in the mitochondria of human osteosarcoma SaOs-2 and hepatocarcinoma HepG2 cell lines. Biochem Biophys Acta 2005; 1745: 382-392.
44. Safe S. Transcriptional activation of genes by 17-beta-estradiol through estrogen receptor-SP1 interactions. Vitam Horm 2001; 62: 231-252.
45. Tsytsykova AV, Tsitsikov EN, Geha RS. The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J Biol Chem 1996; 271: 3763-3770.
46. McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002; 108: 465-474.
47. Evinger AJ, Levin ER. Requirements for estrogen receptor alpha membrane localization and function. Steroids 2005; 70: 361-363.
48. Levin ER. Integration of the extra-nuclear and nuclear action of estrogen. Mol Endocrinol 2005; 19: 1951-1959.
49. Yi Y, McNerney M, Datta SK. Regulatory defects in Cb1 and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J Immunol 2000; 165: 6627-6634.
50. Vassilopoulos D, Kovacs B, Tsokos GC. TCR/CD3 complex-mediate signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J Immunol 1995; 155: 2269-2281.
51. Toubi E, Shoenfeld Y. The role of CD40-CD154 interactions in auto-immunity and the benefit of disrupting this pathway. Autoimmunity 2004; 37: 457-464.
52. Doria A, Iaccarino L, Arienti S et al. Th2 immune deviation induced by pregnancy: The two faces of autoimmune rheumatic diseases. Reprod Toxicol 2006; 22: 234-241.
53. Cutolo M, Seriolo B, Villaggio B, Pizzorni C, Craviotto C, Sulli A. Androgens and estrogen modulate the immune and inflammatory responses in rheumatoid arthritis. Ann NY Acad Sci 2002; 966: 131-142.
54. Rider V, Li X, Peterson G, Dawson J, Kimler BF, Abdou NI. Differential expression of estrogen receptors in women with systemic lupus erythematosus. J Rheumatol 2006; 33: 1093-1101.